CDK4 and cancer: Serial single-cell RNA sequencing of estrogen receptor-positive (ER + ) breast tumors from multiple patient cohorts, combined with experimental analyses, uncovers molecular mechanisms of compensatory growth signaling that drives proliferation in endocrine +/- CDK4/6 inhibitor-resistant cancer cells.